v3.25.1
BALANCE SHEETS - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current assets    
Cash $ 155,647 $ 236,340
Restricted cash 0 100,000
Accounts receivable, net 6,966 172,101
Note receivable 3,500,000
Equity investment 466,500
Inventories 212,494 337,873
Prepaid expenses and other 33,830 42,943
Interest receivable 36,888
Total current assets 4,412,325 889,257
Other assets    
Equity investment 500,000
Total other assets 500,000
Total assets 4,412,325 1,389,257
Current liabilities    
Accounts payable 1,108,777 509,337
Settlement payable 484,735 585,976
Accrued expenses 596,610 810,723
Accrued expenses - related parties 309,333 309,333
Convertible notes payable 432,105
Deferred revenue 1,919 3,407
Total current liabilities 2,933,479 2,218,776
Total liabilities 2,933,479 2,218,776
Stockholders’ equity (deficit)    
Common stock, $0.001 par value - 100,000,000 shares authorized at December 31, 2024 and 2023; 16,713,398 and 15,976,227 shares issued and outstanding at December 31, 2024 and 2023, respectively 16,713 15,976
Additional paid-in capital 30,620,875 25,631,255
Accumulated deficit (29,158,801) (26,476,760)
Total stockholders’ equity (deficit) 1,478,846 (829,519)
Total liabilities and stockholders’ equity (deficit) 4,412,325 1,389,257
Series A Preferred Stock [Member]    
Stockholders’ equity (deficit)    
Series B preferred stock, $0.001 par value – 50,000 and 0 shares authorized at December 31, 2024 and 2023, respectively; 50,000 and 0 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively, preference is liquidation of $7,500,000 and $0 at December 31, 2024 and 2023, respectively. 9 10
Series B Preferred Stock [Member]    
Stockholders’ equity (deficit)    
Series B preferred stock, $0.001 par value – 50,000 and 0 shares authorized at December 31, 2024 and 2023, respectively; 50,000 and 0 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively, preference is liquidation of $7,500,000 and $0 at December 31, 2024 and 2023, respectively. $ 50

Source